Anuh Pharma Limited has informed the Exchange regarding the Audited Financial Results for the Board meeting held on May 23, 2025.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has submitted its audited financial results to the NSE following a board meeting held on May 23, 2025. The filing is a standard compliance disclosure informing the exchange that the board has approved and released the company's audited financial performance. Detailed figures such as revenue, profit after tax, margins, and auditor observations are not included in the headline and would need to be reviewed in the full results document. This is a routine regulatory filing tied to the company's annual results announcement.
No immediate stock price impact is expected from the filing itself, as it is a procedural disclosure confirming submission of results. Investors should review the detailed audited numbers separately to assess the company's actual financial performance and any year-on-year trends.